scPharmaceuticals SCPH
-
-
-
已收盤:-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
---|---|---|---|---|---|---|
2024Q2 | 4.35 | 9 | -101.08 | -17 | -23.75 | 65 |
2024Q1 | 5.02 | 25 | -45.67 | -14 | -16.32 | 78 |
2023Q4 | 6.27 | 37 | -31.99 | -14 | -13.77 | 94 |
2023Q3 | 7.12 | 49 | -27.78 | -16 | -14.20 | 106 |
2023Q2 | 10.19 | 63 | -20.33 | -14 | -11.72 | 114 |
2023Q1 | 9.07 | 76 | -15.12 | -11 | -8.91 | 127 |
2022Q4 | 7.17 | 72 | -17.86 | -9 | -10.72 | 124 |
2022Q3 | 6.52 | 31 | -28.40 | -10 | -18.90 | 48 |
2022Q2 | 4.82 | 40 | -21.58 | -10 | -15.15 | 59 |
2022Q1 | 5.68 | 49 | -14.61 | -8 | -10.45 | 69 |
2021Q4 | 5.02 | 56 | -12.24 | -7 | -8.79 | 79 |
2021Q3 | 6.65 | 63 | -9.92 | -7 | -7.23 | 88 |
2021Q2 | 6.11 | 69 | -9.77 | -7 | -7.28 | 94 |
2021Q1 | 6.65 | 76 | -9.01 | -7 | -6.79 | 100 |
2020Q4 | 5.29 | 82 | -9.05 | -8 | -6.89 | 109 |
2020Q3 | 7.45 | 90 | -9.62 | -9 | -7.50 | 117 |
2020Q2 | 7.36 | 98 | -10.83 | -8 | -8.12 | 124 |
2020Q1 | 7.40 | 55 | -13.32 | -7 | -8.99 | 80 |
2019Q4 | 5.66 | 51 | -19.80 | -11 | -13.19 | 77 |
2019Q3 | 5.87 | 58 | -10.23 | -6 | -7.30 | 87 |